Other OTC - Delayed Quote USD

ViaDerma, Inc. (VDRM)

0.0099 0.0000 (0.00%)
As of April 23 at 3:46 PM EDT. Market Open.
Loading Chart for VDRM
DELL
  • Previous Close 0.0099
  • Open 0.0095
  • Bid --
  • Ask --
  • Day's Range 0.0099 - 0.0099
  • 52 Week Range 0.0080 - 0.0180
  • Volume 2,171,169
  • Avg. Volume 1,649,212
  • Market Cap (intraday) 83,765
  • Beta (5Y Monthly) -0.18
  • PE Ratio (TTM) 0.04
  • EPS (TTM) 0.2800
  • Earnings Date Apr 1, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

viadermalicensing.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VDRM

Performance Overview: VDRM

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VDRM
10.00%
S&P 500
6.26%

1-Year Return

VDRM
41.76%
S&P 500
22.62%

3-Year Return

VDRM
34.00%
S&P 500
21.25%

5-Year Return

VDRM
395.00%
S&P 500
72.76%

Compare To: VDRM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VDRM

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.35

  • Enterprise Value/EBITDA

    0.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -91.23%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    44.69k

  • Net Income Avi to Common (ttm)

    -1.52M

  • Diluted EPS (ttm)

    0.2800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.08k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    688.4k

Company Insights: VDRM

People Also Watch